Closed tender
Bulk Cell Culture Facility
Details
- Value
- GBP 150,000
- Topic
- Laboratory building construction work
- Published
- 7 December 2021
- Submission
- 28 January 2022
- Source
- uk:contracts_finder
Tender description
The National Institute for Biological Standards and Control (NIBSC) has identified that it requires the advanced therapies laboratory to be made into Bulk Cell Culture (BCC) facility under positive pressure. To register Go to https://health-family.force.com/s/Welcome
Timeline
- Completed: Tender published7 December 2021Current notice
- Completed: Submission date28 January 2022
About the buyer
Medicines and Healthcare products Regulatory Agency is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 45214610 · Laboratory building construction work
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@medicines-and-healthcare-products-regulatory-agency.gov |
Related buyers
Buyers similar to Medicines and Healthcare products Regulatory Agency.
BuyersCountValue
- 2,568£1.6bn
- 1,668£204.4bn
- 867£19.4bn
- 664£8.7bn
- 451£15.4bn
- 418£3.8bn
- 327£19.7m
- 275£364.7m
- 253£232.5m
- 250£889.6m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
